Psychiatrists urge action in preparation for new dementia treatments
Psychiatrists urge action in preparation for new dementia treatments
Provider: RC PSYCH ROYAL COLLEGE OF PSYCHIATRISTS
Type: Link
Title: Royal College of Psychiatrists
Description: The Royal College of Psychiatrists is the professional body responsible for education and training, and setting and raising standards in psychiatry.
Psychiatrists urge action in preparation for new dementia treatments
Provider: Health Careers
Type: Link
Title: Old age psychiatry
Description: Download transcript In this video Dr Alex Bailey, Consultant old age psychiatrist, gives an insight into his working life and also the nature of the demands and rewards that come from working in the community with elderly people and the type of person that it would suit as a career. You can also watch a video of Sarah, a trainee in old age psychiatry, talking about her experiences. Nature of the work Mental health problems in older people are increasingly being recognised as a major health issue.
Psychiatrists urge action in preparation for new dementia treatments
Provider: Alzheimer's Research UK
Type: Link
Title: Are we ready to deliver disease modifying treatments? | Alzheimer's Research UK
Description: Old Age Psychiatrists’ views on diagnosing and treating Alzheimer’s disease before dementia
Psychiatrists urge action in preparation for new dementia treatments
Provider: Alzheimersresearchuk
Type: JPG
Psychiatrists urge action in preparation for new dementia treatments
Provider: Alzheimersresearchuk
Type: JPG
Psychiatrists urge action in preparation for new dementia treatments
Provider: Alzheimer's Research UK
Type: Link
Title: The Right to Know: Accurate and Earlier Diagnosis of Dementia | Alzheimer's Research UK
Description: Our vision of how to progressively reform and build dementia diagnostics capability in the UK.
Psychiatrists urge action in preparation for new dementia treatments
Provider: Alzheimer's Research UK
Type: Link
Title: Psychiatrists urge action in preparation for new dementia treatments | Alzheimer's Research UK
Description: 36% of Psychiatrists think their services would be ready to deliver a new dementia treatment in a year Research published today from Alzheimer’s Research UK and The Royal College of Psychiatrists has highlighted significant gaps in support and resources that need to be addressed so that old age psychiatrists can effectively diagnose people with Alzheimer’s…
Psychiatrists urge action in preparation for new dementia treatments
Provider: Alzheimer's Research UK
Type: Link
Title: Alzheimer's Research UK - the UK's leading Alzheimer's research charity
Description: Alzheimer's Research UK are the UK's leading Alzheimer's research charity aiming to find a cure for dementia. Together we have the power to make breakthroughs possible.
Psychiatrists urge action in preparation for new dementia treatments
Provider: View Original
Type: Link
Title: Psychiatrists urge action in preparation for new dementia treatments | Alzheimer's Research UK
Description: 36% of Psychiatrists think their services would be ready to deliver a new dementia treatment in a year Research published today from Alzheimer’s Research UK and The Royal College of Psychiatrists has highlighted significant gaps in support and resources that need to be addressed so that old age psychiatrists can effectively diagnose people with Alzheimer’s…
Olympics hockey hero Imran Sherwani reveals he has Alzheimer’s
Olympics hockey hero Imran Sherwani reveals he has Alzheimer’s
Provider: Just Giving
Type: Link
Title: Going for Gold - London Marathon 2021
Olympics hockey hero Imran Sherwani reveals he has Alzheimer’s
Provider: Alzheimer's Research UK
Type: Link
Title: Olympics hockey hero Imran Sherwani reveals he has Alzheimer’s | Alzheimer's Research UK
Description: Olympic hero Imran Sherwani shares his diagnosis of early-onset Alzheimer's disease as former team mate Steve Batchelor, who was also in the victorious Seoul Olympics side, has set up a team for this year’s Virgin Money London Marathon to raise money for Alzheimer’s Research UK inhis friend's honour.
Olympics hockey hero Imran Sherwani reveals he has Alzheimer’s
Provider: Alzheimer's Research UK
Type: Link
Title: Alzheimer's Research UK - the UK's leading Alzheimer's research charity
Description: Alzheimer's Research UK are the UK's leading Alzheimer's research charity aiming to find a cure for dementia. Together we have the power to make breakthroughs possible.
Olympics hockey hero Imran Sherwani reveals he has Alzheimer’s
Provider: View Original
Type: Link
Title: Olympics hockey hero Imran Sherwani reveals he has Alzheimer’s | Alzheimer's Research UK
Description: Olympic hero Imran Sherwani shares his diagnosis of early-onset Alzheimer's disease as former team mate Steve Batchelor, who was also in the victorious Seoul Olympics side, has set up a team for this year’s Virgin Money London Marathon to raise money for Alzheimer’s Research UK inhis friend's honour.
FDA approves licence for Alzheimer’s drug aducanumab in US
FDA approves licence for Alzheimer’s drug aducanumab in US
Provider: Alzheimer's Research UK
Type: Link
Title: Our letter to Matt Hancock on aducanumab | Alzheimer's Research UK
Description: Today the FDA in the US made a landmark decision to approve the Alzheimer’s drug aducanumab for mild cognitive impairment and early Alzheimer’s disease. The drug has been approved under the FDA’s Accelerated Approval pathway, which includes a requirement for Biogen, the pharmaceutical company that makes the drug, to conduct a further stage four clinical…
FDA approves licence for Alzheimer’s drug aducanumab in US
Provider: Alzheimersresearchuk
Type: JPG
FDA approves licence for Alzheimer’s drug aducanumab in US
Provider: Alzheimer's Research UK
Type: Link
Title: When could aducanumab reach the UK? | Alzheimer's Research UK
Description: Today is a historic day for dementia research with the US Food and Drug Administration (FDA) announcing the first (conditional) licence of a new drug for Alzheimer’s disease in a generation.
FDA approves licence for Alzheimer’s drug aducanumab in US
Provider: Alzheimer's Research UK
Type: Link
Title: FDA approves licence for Alzheimer’s drug aducanumab in US | Alzheimer's Research UK
Description: The US Food and Drug Administration (FDA) has announced that it has granted a conditional licence for the drug aducanumab in people with a confirmed diagnosis of mild cognitive impairment (MCI) or mild Alzheimer’s disease in the US, pending further clinical trials. This marks the first time a drug has been approved for dementia treatment in nearly 20 years
FDA approves licence for Alzheimer’s drug aducanumab in US
Provider: Alzheimer's Research UK
Type: Link
Title: Alzheimer's Research UK - the UK's leading Alzheimer's research charity
Description: Alzheimer's Research UK are the UK's leading Alzheimer's research charity aiming to find a cure for dementia. Together we have the power to make breakthroughs possible.
FDA approves licence for Alzheimer’s drug aducanumab in US
Provider: View Original
Type: Link
Title: FDA approves licence for Alzheimer’s drug aducanumab in US | Alzheimer's Research UK
Description: The US Food and Drug Administration (FDA) has announced that it has granted a conditional licence for the drug aducanumab in people with a confirmed diagnosis of mild cognitive impairment (MCI) or mild Alzheimer’s disease in the US, pending further clinical trials. This marks the first time a drug has been approved for dementia treatment in nearly 20 years
“Dementia will rob me of my life – let’s make sure this changes for future generations”
“Dementia will rob me of my life – let’s make sure this changes for future generations”
Provider: Alzheimer's Research UK
Type: Link
Title: Dementia Research at Risk Petition
Description: We must protect the future of dementia research. The government made an election pledge to double funding for dementia research to over £160 million a year. Together, we can make sure they keep their promise.
“Dementia will rob me of my life – let’s make sure this changes for future generations”
Provider: Alzheimer's Research UK
Type: Link
Title: FDA approves licence for Alzheimer’s drug aducanumab in US | Alzheimer's Research UK
Description: The US Food and Drug Administration (FDA) has announced that it has granted a conditional licence for the drug aducanumab in people with a confirmed diagnosis of mild cognitive impairment (MCI) or mild Alzheimer’s disease in the US, pending further clinical trials. This marks the first time a drug has been approved for dementia treatment in nearly 20 years
“Dementia will rob me of my life – let’s make sure this changes for future generations”
Provider: Alzheimersresearchuk
Type: Link
“Dementia will rob me of my life – let’s make sure this changes for future generations”
Provider: Alzheimersresearchuk
Type: JPG
“Dementia will rob me of my life – let’s make sure this changes for future generations”
Provider: Alzheimer's Research UK
Type: Link
Title: “Dementia will rob me of my life - let’s make sure this changes for future generations” | Alzheimer's Research UK
Description: More than 50,000 people have signed Alzheimer Research UK’s petition urging the government to double its funding for dementia research, which was today handed in to Number 10 Downing Street. Campaigner, Olive Munro, who was diagnosed with vascular dementia in 2015, has written to the Prime Minister to urge the government to honour their pledge…
“Dementia will rob me of my life – let’s make sure this changes for future generations”
Provider: Alzheimer's Research UK
Type: Link
Title: Alzheimer's Research UK - the UK's leading Alzheimer's research charity
Description: Alzheimer's Research UK are the UK's leading Alzheimer's research charity aiming to find a cure for dementia. Together we have the power to make breakthroughs possible.
“Dementia will rob me of my life – let’s make sure this changes for future generations”
Provider: View Original
Type: Link
Title: “Dementia will rob me of my life - let’s make sure this changes for future generations” | Alzheimer's Research UK
Description: More than 50,000 people have signed Alzheimer Research UK’s petition urging the government to double its funding for dementia research, which was today handed in to Number 10 Downing Street. Campaigner, Olive Munro, who was diagnosed with vascular dementia in 2015, has written to the Prime Minister to urge the government to honour their pledge…
Drugs fail to slow memory and thinking decline in rare genetic form of Alzheimer’s
Drugs fail to slow memory and thinking decline in rare genetic form of Alzheimer’s
Provider: Alzheimer's Research UK
Type: Link
Title: Drug trial fails to slow memory and thinking decline in rare genetic form of Alzheimer’s | Alzheimer's Research UK
Description: DIAN-TU an international clinical trial testing the potential Alzheimer’s drugs, solanezumab and gantenerumab, in people with a rare, form of Alzheimer's.
Drugs fail to slow memory and thinking decline in rare genetic form of Alzheimer’s
Provider: Alzheimersresearchuk
Type: JPG
Drugs fail to slow memory and thinking decline in rare genetic form of Alzheimer’s
Provider: Nature Medicine
Type: Link
Title: A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
Description: Results from the phase 2/3 clinical trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease reveal no beneficial effects on cognitive measures despite a significant reduction in amyloid plaques and other key biomarkers in those treated with gantenerumab.
Drugs fail to slow memory and thinking decline in rare genetic form of Alzheimer’s
Provider: Alzheimer's Research UK
Type: Link
Title: Drugs fail to slow memory and thinking decline in rare genetic form of Alzheimer’s | Alzheimer's Research UK
Description: Full results of the genetic form of Alzheimer's disease clinical trial (DIAN TU) are now published. There was no benefit of the drugs on memory...
Drugs fail to slow memory and thinking decline in rare genetic form of Alzheimer’s
Provider: Alzheimer's Research UK
Type: Link
Title: Alzheimer's Research UK - the UK's leading Alzheimer's research charity
Description: Alzheimer's Research UK are the UK's leading Alzheimer's research charity aiming to find a cure for dementia. Together we have the power to make breakthroughs possible.
Drugs fail to slow memory and thinking decline in rare genetic form of Alzheimer’s
Provider: View Original
Type: Link
Title: Drugs fail to slow memory and thinking decline in rare genetic form of Alzheimer’s | Alzheimer's Research UK
Description: Full results of the genetic form of Alzheimer's disease clinical trial (DIAN TU) are now published. There was no benefit of the drugs on memory...
Blood pressure drugs that can cross the blood brain barrier have impact on memory
Blood pressure drugs that can cross the blood brain barrier have impact on memory
Provider: Alzheimersresearchuk
Type: JPG
Blood pressure drugs that can cross the blood brain barrier have impact on memory
Provider: Hypertension
Type: Link
Title: Blood-Brain Barrier Crossing Renin-Angiotensin Drugs and Cognition in the Elderly: A Meta-Analysis
Description: Hypertension is an established risk factor for cognitive decline and dementia in older adults, highlighting the potential importance of antihypertensive treatments in prevention efforts. Work surroun
Blood pressure drugs that can cross the blood brain barrier have impact on memory
Provider: Alzheimer's Research UK
Type: Link
Title: Keeping blood pressure in check | Think Brain Health | Alzheimer's Research UK
Description: There’s strong evidence linking blood pressure in midlife with brain health in later life, with a recent study of adults in their 50s concluding that controlling blood pressure at this time could help protect the brain from damage. A third of adults in the UK have high blood pressure, though many won’t realise it. If…
Blood pressure drugs that can cross the blood brain barrier have impact on memory
Provider: Alzheimer's Research UK
Type: Link
Title: Blood pressure drugs that can cross the blood brain barrier have impact on memory | Alzheimer's Research UK
Description: Drugs to treat high blood pressure that can cross the blood brain barrier have impact on memory and thinking.
Blood pressure drugs that can cross the blood brain barrier have impact on memory
Provider: Alzheimer's Research UK
Type: Link
Title: Alzheimer's Research UK - the UK's leading Alzheimer's research charity
Description: Alzheimer's Research UK are the UK's leading Alzheimer's research charity aiming to find a cure for dementia. Together we have the power to make breakthroughs possible.
Blood pressure drugs that can cross the blood brain barrier have impact on memory
Provider: View Original
Type: Link
Title: Blood pressure drugs that can cross the blood brain barrier have impact on memory | Alzheimer's Research UK
Description: Drugs to treat high blood pressure that can cross the blood brain barrier have impact on memory and thinking.